339 related articles for article (PubMed ID: 17405826)
1. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway.
Delhanty PJ; van Koetsveld PM; Gauna C; van de Zande B; Vitale G; Hofland LJ; van der Lely AJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E302-9. PubMed ID: 17405826
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a.
Delhanty PJ; van der Eerden BC; van der Velde M; Gauna C; Pols HA; Jahr H; Chiba H; van der Lely AJ; van Leeuwen JP
J Endocrinol; 2006 Jan; 188(1):37-47. PubMed ID: 16394173
[TBL] [Abstract][Full Text] [Related]
3. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects.
Mazzocchi G; Neri G; Rucinski M; Rebuffat P; Spinazzi R; Malendowicz LK; Nussdorfer GG
Peptides; 2004 Aug; 25(8):1269-77. PubMed ID: 15350694
[TBL] [Abstract][Full Text] [Related]
5. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor.
Gauna C; Delhanty PJ; van Aken MO; Janssen JA; Themmen AP; Hofland LJ; Culler M; Broglio F; Ghigo E; van der Lely AJ
Mol Cell Endocrinol; 2006 Jun; 251(1-2):103-11. PubMed ID: 16647196
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
[TBL] [Abstract][Full Text] [Related]
7. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells.
Kim SW; Her SJ; Park SJ; Kim D; Park KS; Lee HK; Han BH; Kim MS; Shin CS; Kim SY
Bone; 2005 Sep; 37(3):359-69. PubMed ID: 15978880
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines.
Jeffery PL; Murray RE; Yeh AH; McNamara JF; Duncan RP; Francis GD; Herington AC; Chopin LK
Endocr Relat Cancer; 2005 Dec; 12(4):839-50. PubMed ID: 16322325
[TBL] [Abstract][Full Text] [Related]
10. Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R).
Gauna C; van de Zande B; van Kerkwijk A; Themmen AP; van der Lely AJ; Delhanty PJ
Mol Cell Endocrinol; 2007 Aug; 274(1-2):30-4. PubMed ID: 17601657
[TBL] [Abstract][Full Text] [Related]
11. Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells.
De Vriese C; Delporte C
J Endocrinol; 2007 Jan; 192(1):199-205. PubMed ID: 17210757
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin directly regulates bone formation.
Fukushima N; Hanada R; Teranishi H; Fukue Y; Tachibana T; Ishikawa H; Takeda S; Takeuchi Y; Fukumoto S; Kangawa K; Nagata K; Kojima M
J Bone Miner Res; 2005 May; 20(5):790-8. PubMed ID: 15824852
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes.
Iglesias MJ; Piñeiro R; Blanco M; Gallego R; Diéguez C; Gualillo O; González-Juanatey JR; Lago F
Cardiovasc Res; 2004 Jun; 62(3):481-8. PubMed ID: 15158140
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor.
Ghigo E; Broglio F; Arvat E; Maccario M; Papotti M; Muccioli G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):1-17. PubMed ID: 15638864
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
[TBL] [Abstract][Full Text] [Related]
17. cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells.
Liu J; Li XD; Ora A; Heikkilä P; Vaheri A; Voutilainen R
J Mol Endocrinol; 2004 Oct; 33(2):511-22. PubMed ID: 15525605
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
[TBL] [Abstract][Full Text] [Related]
20. Effects of ghrelin and its analogues on chicken ovarian granulosa cells.
Sirotkin AV; Grossmann R
Domest Anim Endocrinol; 2008 Feb; 34(2):125-34. PubMed ID: 17207955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]